SCHEMBL19207590

SCHEMBL19207590

[2H]C([2H])([2H])N1C(=O)C(NC(=O)O)COc2cccnc21

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21496688 0.92 RIPK1 (0.65) RIPK1
SCHEMBL21496687 0.92 RIPK1 (0.65) RIPK1
SCHEMBL21496580 0.85 RIPK1 (0.49) RIPK1
SCHEMBL25875210 0.82 RIPK1 (0.62) RIPK1
Eclitasertib SCHEMBL19207582 0.82 RIPK1 (0.69) RIPK1
Eclitasertib SCHEMBL19207584 0.82 RIPK1 (0.69) RIPK1
SCHEMBL19207816 0.79 RIPK1 (0.89) RIPK1
SCHEMBL19207815 0.79 RIPK1 (0.89) RIPK1
SCHEMBL21496559 0.78 RIPK1 (0.41) RIPK1
SCHEMBL19207948 0.78 RIPK1 (0.89) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed